John S. Schieffelin

25.6k total citations
63 papers, 1.0k citations indexed

About

John S. Schieffelin is a scholar working on Infectious Diseases, Emergency Medical Services and Epidemiology. According to data from OpenAlex, John S. Schieffelin has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 22 papers in Emergency Medical Services and 17 papers in Epidemiology. Recurrent topics in John S. Schieffelin's work include Viral Infections and Outbreaks Research (40 papers), Viral Infections and Vectors (22 papers) and Disaster Response and Management (22 papers). John S. Schieffelin is often cited by papers focused on Viral Infections and Outbreaks Research (40 papers), Viral Infections and Vectors (22 papers) and Disaster Response and Management (22 papers). John S. Schieffelin collaborates with scholars based in United States, Sierra Leone and United Kingdom. John S. Schieffelin's co-authors include Donald S. Grant, Robert F. Garry, Jeffrey G. Shaffer, Lina Moses, Augustine Goba, M Dietrich, Randall Craver, James E. Robinson, Joshua M. Costin and Sharon Isern and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

John S. Schieffelin

59 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Schieffelin United States 18 780 274 238 212 98 63 1.0k
Tim Brooks United Kingdom 21 950 1.2× 272 1.0× 200 0.8× 207 1.0× 280 2.9× 59 1.4k
Ian Crozier United States 16 909 1.2× 167 0.6× 301 1.3× 288 1.4× 99 1.0× 44 1.2k
Shelley Campbell United States 13 773 1.0× 150 0.5× 248 1.0× 171 0.8× 50 0.5× 17 922
Roosecelis B. Martines United States 17 1.1k 1.4× 726 2.6× 405 1.7× 71 0.3× 73 0.7× 36 1.6k
Danielle V. Clark United States 13 305 0.4× 199 0.7× 148 0.6× 95 0.4× 147 1.5× 42 729
Stefan Schilling Germany 12 623 0.8× 309 1.1× 74 0.3× 117 0.6× 62 0.6× 36 949
Augustine Goba United States 17 926 1.2× 131 0.5× 285 1.2× 285 1.3× 104 1.1× 24 1.0k
Mark G. Kortepeter United States 16 628 0.8× 177 0.6× 158 0.7× 245 1.2× 187 1.9× 37 884
Manuel Schibler Switzerland 22 1.1k 1.4× 69 0.3× 356 1.5× 95 0.4× 176 1.8× 52 1.5k
Emma Aarons United Kingdom 22 891 1.1× 309 1.1× 327 1.4× 85 0.4× 201 2.1× 49 1.6k

Countries citing papers authored by John S. Schieffelin

Since Specialization
Citations

This map shows the geographic impact of John S. Schieffelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Schieffelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Schieffelin more than expected).

Fields of papers citing papers by John S. Schieffelin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Schieffelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Schieffelin. The network helps show where John S. Schieffelin may publish in the future.

Co-authorship network of co-authors of John S. Schieffelin

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Schieffelin. A scholar is included among the top collaborators of John S. Schieffelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Schieffelin. John S. Schieffelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muwonge, Haruna, Barnabas Bakamutumaho, Peter Elyanu, et al.. (2025). Long-term clinical sequelae among Sudan ebolavirus disease survivors 2 years post-infection: a matched cohort study. BMC Medicine. 23(1). 432–432. 1 indexed citations
2.
Zifodya, Jerry S., et al.. (2025). A systematic review of the immuno-inflammatory dysfunction secondary to viral hemorrhagic fevers; Ebola and Lassa fever. PLoS neglected tropical diseases. 19(6). e0013230–e0013230. 2 indexed citations
3.
Crea, Thomas M., Stephen Sevalie, Joseph Benjamin Bangura, et al.. (2025). Stressors and coping strategies among people affected by Ebola Virus Disease (EVD) in West Africa: A qualitative study across multiple levels of the social ecology. Heliyon. 11(6). e43040–e43040.
4.
Sabino‐Santos, Gilberto, Sam Litwin, Debra Elliott, et al.. (2024). Post‐COVID immunity in patients with solid tumor or hematological malignancies treated with SARS‐CoV‐2 monoclonal antibodies. Immunity Inflammation and Disease. 12(12). e70039–e70039. 1 indexed citations
5.
Perrett, Hailee R., Philip J. M. Brouwer, Jonathan Hurtado, et al.. (2023). Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies. Cell Reports. 42(5). 112524–112524. 14 indexed citations
6.
Tjaden, Ashley H., David M. Herrington, John S. Schieffelin, et al.. (2023). COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA. Emerging infectious diseases. 29(1). 207–211. 16 indexed citations
7.
Berry, Andrea A., Ashley H. Tjaden, DeAnna Friedman-Klabanoff, et al.. (2023). Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership. Vaccine X. 15. 100371–100371. 2 indexed citations
8.
Moon, Troy D., Leigh M. Howard, Ann Green, et al.. (2023). Antibiotic prescribing practices for acute respiratory illness in children less than 24 months of age in Kenema, Sierra Leone: is it time to move beyond algorithm driven decision making?. BMC Infectious Diseases. 23(1). 626–626. 2 indexed citations
9.
Grant, Donald S., Mohamed Yillah, Edwin Konuwa, et al.. (2022). The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone. BMC Infectious Diseases. 22(1). 624–624. 2 indexed citations
10.
Dagher, Lilas, Hanyuan Shi, Yan Zhao, et al.. (2021). New‐onset atrial arrhythmias associated with mortality in black and white patients hospitalized with COVID‐19. Pacing and Clinical Electrophysiology. 44(5). 856–864. 9 indexed citations
11.
Akpogheneta, Onome, Donald S. Grant, Lansana Kanneh, et al.. (2021). Boosting understanding of Lassa Fever virus epidemiology: Field testing a novel assay to identify past Lassa Fever virus infection in blood and oral fluids of survivors and unexposed controls in Sierra Leone. PLoS neglected tropical diseases. 15(3). e0009255–e0009255. 2 indexed citations
12.
Kanneh, Lansana, Paul H. Wise, Lianne M. Kurina, et al.. (2021). Health seeking behavior after the 2013–16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone. PLoS neglected tropical diseases. 15(7). e0009576–e0009576. 10 indexed citations
13.
Grant, Donald S., Michael Gbakie, Fatima Kamara, et al.. (2021). Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone. Clinical Infectious Diseases. 73(6). 1046–1054. 22 indexed citations
14.
Shantha, Jessica G., Ian Crozier, Colleen S. Kraft, et al.. (2021). Implementation of the Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) study: Lessons learned for vision health systems strengthening in Sierra Leone. PLoS ONE. 16(7). e0252905–e0252905. 6 indexed citations
15.
Bays, Alison, Augustine Goba, Michael Gbakie, et al.. (2020). Lassa Fever Induced Hearing Loss: The Neglected Disability of Hemorrhagic Fever. International Journal of Infectious Diseases. 100. 82–87. 19 indexed citations
16.
Jain, Priya, et al.. (2020). Responses of three urban U.S. Children’s Hospitals to COVID-19: Seattle, New York and New Orleans. Paediatric Respiratory Reviews. 35. 15–19. 9 indexed citations
17.
Shaffer, Jeffrey G., John S. Schieffelin, Michael Gbakie, et al.. (2019). A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges. PLoS ONE. 14(3). e0214284–e0214284. 11 indexed citations
18.
Iacono, Giovanni Lo, Andrew A. Cunningham, Élisabeth Fichet-Calvet, et al.. (2016). A Unified Framework for the Infection Dynamics of Zoonotic Spillover and Spread. PLoS neglected tropical diseases. 10(9). e0004957–e0004957. 45 indexed citations
19.
Yozwiak, Nathan L., Christian Happi, Donald S. Grant, et al.. (2016). Roots, Not Parachutes: Research Collaborations Combat Outbreaks. Cell. 166(1). 5–8. 36 indexed citations
20.
Schieffelin, John S.. (2015). Treatment of Arenavirus Infections. Current treatment options in infectious diseases. 7(3). 261–270. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026